Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2020 February;155(1) > Giornale Italiano di Dermatologia e Venereologia 2020 February;155(1):46-64

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Giornale Italiano di Dermatologia e Venereologia 2020 February;155(1):46-64

DOI: 10.23736/S0392-0488.19.06517-9

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Updates on diagnosis and management of autoimmune blistering diseases

Emily F. COLE 1, Naveed SAMI 2 , Ron J. FELDMAN 1

1 Emory Autoimmune Blistering Disease Clinic, Emory Department of Dermatology, Atlanta, GA, USA; 2 Department of Dermatology, University of Central Florida, Orlando, FL, USA



Over the last several decades, advances in the understanding of the pathogenesis of autoimmune blistering diseases has resulted in significant improvements in diagnosis and management. These improvements include new diagnostic assays and therapies targeted at specific disease mediators. Furthermore, the abundance of new therapies in clinic trials for autoimmune blistering diseases will translate to an enhanced therapeutic armamentarium for clinicians. The aim of this article is to review new developments in the understanding of autoimmune blistering diseases and to summarize advancements in their diagnosis and management.


KEY WORDS: Autoimmune diseases; Blister; Pemphigus; Bullous pemphigoid

top of page